Literature DB >> 11416176

Molecular matchmaking: NNRTIs can enhance the dimerization of HIV type 1 reverse transcriptase.

S H Hughes1.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11416176      PMCID: PMC34610          DOI: 10.1073/pnas.141222698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  10 in total

1.  Reverse transcriptase of human immunodeficiency virus type 1: functionality of subunits of the heterodimer in DNA synthesis.

Authors:  Z Hostomsky; Z Hostomska; T B Fu; J Taylor
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention.

Authors:  T Restle; B Müller; R S Goody
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

3.  HIV-1 reverse transcriptase: polymerization properties of the p51 homodimer compared to the p66/p51 heterodimer.

Authors:  M R Bavand; R Wagner; T J Richmond
Journal:  Biochemistry       Date:  1993-10-12       Impact factor: 3.162

4.  Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase.

Authors:  G Tachedjian; M Orlova; S G Sarafianos; E Arnold; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

5.  Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.

Authors:  A Jacobo-Molina; J Ding; R G Nanni; A D Clark; X Lu; C Tantillo; R L Williams; G Kamer; A L Ferris; P Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

6.  Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors.

Authors:  K Rittinger; G Divita; R S Goody
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.

Authors:  L A Kohlstaedt; J Wang; J M Friedman; P A Rice; T A Steitz
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

8.  Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance.

Authors:  Y Hsiou; K Das; J Ding; A D Clark; J P Kleim; M Rösner; I Winkler; G Riess; S H Hughes; E Arnold
Journal:  J Mol Biol       Date:  1998-11-27       Impact factor: 5.469

9.  Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors.

Authors:  R A Spence; W M Kati; K S Anderson; K A Johnson
Journal:  Science       Date:  1995-02-17       Impact factor: 47.728

10.  Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase.

Authors:  S F Le Grice; T Naas; B Wohlgensinger; O Schatz
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

  10 in total
  4 in total

1.  Conformational Changes in HIV-1 Reverse Transcriptase that Facilitate Its Maturation.

Authors:  Ryan L Slack; Tatiana V Ilina; Zhaoyong Xi; Nicholas S Giacobbi; Gota Kawai; Michael A Parniak; Stefan G Sarafianos; Nicolas Sluis Cremer; Rieko Ishima
Journal:  Structure       Date:  2019-08-27       Impact factor: 5.006

2.  Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells.

Authors:  Alok Mulky; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

3.  Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.

Authors:  Alok Mulky; Stefan G Sarafianos; Edward Arnold; Xiaoyun Wu; John C Kappes
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  Hepatitis C virus, human immunodeficiency virus and Pseudomonas phage PS5 triad share epitopes of immunogenic determinants.

Authors:  Zhabiz Golkar; Nusrat Jamil
Journal:  Virol J       Date:  2010-11-26       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.